We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Chemotherapy-Related Cognitive Impairment #342.
- Authors
Brewster, Katharine K.; Shalev, Daniel; Levenson, Jon A.
- Abstract
The article discusses the effects, diagnosis, and management of chemotherapy-related cognitive impairment (CRCI) or chemobrain, which is a complication of cancer therapy. Also cited are such cognitive changes due to chemotherapy like changes in memory, attention, processing speeds, and problem solving, the at-risk patients like those with leukemia, breast, prostate, and ovarian cancers, and the screening tools such as the Montreal Cognitive Assessment (MoCA).
- Subjects
COGNITION disorders diagnosis; COGNITION disorder risk factors; BREAST tumors; CANCER chemotherapy; CENTRAL nervous system diseases; COGNITION disorders; GENETICS; PATIENT aftercare; LEUKEMIA; MEDICAL needs assessment; MEMORY; QUALITY of life; THOUGHT &; thinking; PREVENTION
- Publication
Journal of Palliative Medicine, 2017, Vol 20, Issue 12, p1407
- ISSN
1096-6218
- Publication type
Article
- DOI
10.1089/jpm.2017.0524